glp-1 review article receptor agonists and cardiovascular outcome trials: An update Glucagon-like peptide-1 receptor agonists (GLP-1
Description
BMC Physiol
2011;6:e28668
While theyve already changed the world of food and beverage significantly, they show no sign of slowing down
Medvi or Ro for GLP-1 weight loss
In addition to its activity against hyperglycemia, DPP-4i has shown beneficial cardiovascular effects including cardioprotective action, endothelial protection, and an anti-hypertensive effect
